IMAGE: UConn School of Medicine’s Dr. Biree Andemariam presented her latest phase 2 clinical trial findings in Amsterdam at the European Hematology Association meeting in June 2019. view more Credit: Photo by Willem Scheele, Imara Inc. An investigational drug for the treatment of sickle cell disease is showing early promise in clinical trials for impacting biomarkers…
VIDEO: Researchers dove to the mesophotic zone off the coast of Maui, Hawaii, in a submersible, then collected specimens using a robot arm. They also captured video footage and photos of… view more Just beyond where conventional scuba divers can go is an area of the ocean that still is largely unexplored. In waters this deep…
IMAGE: Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway… view more Credit: Huntsman Cancer Institute SALT LAKE CITY – Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered…
NEW YORK, NY (June 19, 2019)–Limiting ovarian cancer surgery to high-volume hospitals could improve survival but may also reduce access for many rural and underserved patients, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found. Although mortality was higher than average at hospitals that performed 3 or fewer…